BIOMARKER REAGENTS MEDICAL

Brand Owner (click to sort) Address Description
NJ Code Biological Medicine Technology Inc. 1920 South Archibald Avenue, Suite J Ontario CA 91761 Biomarker reagents for medical and diagnostic purposes; medical diagnostic kits comprised primarily of diagnostic preparations for medical diagnostic uses, namely, for the preparation of samples, the modification and manipulation of samples and for making, separating, isolating, purifying, reproducing and analyzing biopolymers, namely, nucleic acids, proteins, macromolecules and biologically active substances in the nature of nucleic acids from biological or biochemical sample material; medical diagnostic reagents and assays for testing of body fluids; diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, cancer and tumors; diagnostic preparations for medical and veterinary use;
NJ SP70 Code Biological Medicine Technology Inc. 1920 South Archibald Avenue, Suite J Ontario CA 91761 Biomarker reagents for medical and diagnostic purposes; medical diagnostic kits comprised primarily of diagnostic preparations for medical diagnostic uses, namely, for the preparation of samples, the modification and manipulation of samples and for making, separating, isolating, purifying, reproducing and analyzing biopolymers, namely, nucleic acids, proteins, macromolecules and biologically active substances in the nature of nucleic acids from biological or biochemical sample material; medical diagnostic reagents and assays for testing of body fluids; diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, cancer and tumors; diagnostic preparations for medical and veterinary use;NJ SP SEVENTY; NJ SP SEVEN ZERO;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. Methods and compositions for identifying high-grade cervical disease in a patient sample are provided. The methods of the invention comprise detecting overexpression of at least one biomarker in a body sample, wherein the biomarker is selectively overexpressed in high-grade cervical disease. In particular claims, the body sample is a cervical smear or monolayer of cervical cells. The biomarkers of the invention include genes and proteins that are involved in cell cycle regulation, signal transduction, and DNA replication and transcription. In particular claims, the biomarker is an S-phase gene. In some aspects of the invention, overexpression of a biomarker of interest is detected at the protein level using biomarker-specific antibodies or at the nucleic acid level using nucleic acid hybridization techniques. Kits for practicing the methods of the invention are further provided.